Novo on Monday published full late-stage data showing Wegovy cut weight in obese children aged 6 to under 12 over 68 weeks. Among those who stayed on drug, BMI fell an estimated 19.7 percentage points versus placebo (17.4% vs a 2.2% rise); including dropouts, the advantage was 16.2 points. All 167 c